Melki, R., Gaudin, Y., and Blondel, D. (1994). Interaction between tubulin and the viral matrix protein of Vesicular Stomatitis Virus: Possible implications in the viral cytopathic efTect. Virology 202, 339-347.
Mhawech-Fauceglia, P., Wang, D., Samrao, D., Kim, G., Lawrenson, K., Meneses, T., Liu, S., Yessaian, A., and Pejovic, T. (2013). clinical implications of marker expression of carcinoma-associated fibroblasts (CAFs) in patients with epithelial ovarian carcinoma after treatment with neoadjuvant chemotherapy. Cancer Microenvironment, 1-7.
Mills, B.J., Beebe, D.P., and Cooper, N.R. (1979). Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis. J. Immunol. 123, 2518-2524.
Mirę, C.E., Dube, D., Delos, S.E., White, J.M., and Whitt, M.A. (2009). Glycoprotein-dependent acidification of Vesicular Stomatitis Virus enhances release of matrix protein. J. Virol. 83, 12139-12150.
Morelli, A.E., Larregina, A.T., Shufesky, W.J , Zahorchak, A.F., Logar, A.J., Papworth, G.D., Wang, Z., Watkins, S.C., Falo, L.D., and Thomson, A.W. (2003). Intemalization of circulating apoptotic cells by spienić marginal zonę dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101, 611-620.
Moretta, A., Bottino, C., Mingari, M.C., Biassoni, R., and Moretta, L. (2002). What is a natural killer celi? Nat. Immunol. 3,6-8.
Morón, G., Dadaglio, G., and Leclerc, C. (2004). New tools for antigen delivery to the MHC class I pathway. Trends Immunol. 25,92-97.
Morris, D., Feng, X., DiFrancesco, L., Fonseca, K., Forsyth, P., Paterson, A., Coffey, M., and Thompson, B. (2013). REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin®) in patients with advanced solid tumors. Invest. New Drugs 37,696-706.
Msaouel, P., Dispenzieri, A., and Galanis, E. (2009). Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview. Curr. Opin. Mol. Ther. 77,43-53.